Background: The Sunda porcupine, or the Javan porcupine ), is a rodent native to Indonesia. Although information about its conservation status is available, the hematological profile is limited. The normal hematological profile of an animal is essential as a basic health indicator to determine the initial state of a pathological process of a disease. Since the hematological profile can provide significant evidence regarding the health status of the species, the Sunda Porcupine's hematological profile can benefit conservation initiatives. Therefore, hematological evaluation of these porcupines can play a role in conservation initiatives, breeding strategies, and the prevention of zoonotic diseases.
Aim: This research revealed the routine blood evaluation and white blood cell (WBC) morphological features of the free-ranging Sunda porcupine ().
Methods: Blood samples from four free-range individuals captured Sunda porcupine () were obtained intracardially for routine hematological evaluation and WBC staining for morphological identification. The profiles were then analyzed descriptively.
Results: Hematology profile averages were generally 4.04 × 10/Ul for RBC; Hemoglobin was in 12.83 g/dl; Hematocrit by 37.8%; MCV 107.1 fl; MCH 31.80 pg; MCHC 31.23 g/dl; while WBC and platelet (PLT) were at 9.67 × 10/μl and 503.00 × 10/μl, respectively.
Conclusion: The morphology of red blood cells, WBCs, and the hematological profile of the Javan hedgehog is not much different from that of other mammals such as crested porcupines, ferrets, and guinea pigs. Until now, there has been limited research on the hematology of Sunda porcupines, which has led to a limited understanding of their health status. We anticipate that the findings of this study will serve as a diagnostic instrument for evaluating the health condition of Sunda porcupine and serve as a benchmark.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11563613 | PMC |
http://dx.doi.org/10.5455/OVJ.2024.v14.i9.30 | DOI Listing |
Acta Neuropathol Commun
January 2025
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Recent genomic studies have allowed the subdivision of intracranial ependymomas into molecularly distinct groups with highly specific clinical features and outcomes. The majority of supratentorial ependymomas (ST-EPN) harbor ZFTA-RELA fusions which were designated, in general, as an intermediate risk tumor variant. However, molecular prognosticators within ST-EPN ZFTA-RELA have not been determined yet.
View Article and Find Full Text PDFNat Med
January 2025
Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Predicting whether a patient with cancer will benefit from immune checkpoint inhibitors (ICIs) without resorting to advanced genomic or immunologic assays is an important clinical need. To address this, we developed and evaluated SCORPIO, a machine learning system that utilizes routine blood tests (complete blood count and comprehensive metabolic profile) alongside clinical characteristics from 9,745 ICI-treated patients across 21 cancer types. SCORPIO was trained on data from 1,628 patients across 17 cancer types from Memorial Sloan Kettering Cancer Center.
View Article and Find Full Text PDFNat Med
January 2025
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
The MEK inhibitor selumetinib induces objective responses and provides clinical benefit in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs). To evaluate whether similar outcomes were possible in adult patients, in whom PN growth is generally slower than in pediatric patients, we conducted an open-label phase 2 study of selumetinib in adults with NF1 PNs. The study was designed to evaluate objective response rate (primary objective), tumor volumetric responses, patient-reported outcomes and pharmacodynamic effects in PN biopsies.
View Article and Find Full Text PDFAm J Respir Cell Mol Biol
January 2025
Rostock University Medical Center, Institute of Medical Microbiology, Virology and Hygiene, Rostock, Germany.
(Group A Streptococcus, GAS) is a human pathogen that causes local and systemic infections of the skin and mucous membranes. However, GAS is also found asymptomatically in the nasopharynx of infants. GAS infections, including pharyngitis and invasive pneumosepsis, pose significant public health concerns.
View Article and Find Full Text PDFInflamm Bowel Dis
January 2025
Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, Box 1498, New York, NY 10029, USA.
Background: Clonal hematopoiesis of indeterminate potential (CHIP) is the presence of somatic mutations in myeloid and lymphoid malignancy genes in the blood cells of individuals without a hematologic malignancy. Inflammation is hypothesized to be a key mediator in the progression of CHIP to hematologic malignancy and patients with CHIP have a high prevalence of inflammatory diseases. This study aimed to identify the prevalence and characteristics of CHIP in patients with inflammatory bowel disease (IBD).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!